Raised Alpha-Fetoprotein Levels in Chinese Patients with Liver Cancer
Author Information
Author(s): J.-F. Tsai, W.Y. Chang, J.E. Jeng, M.S. Ho, Z.Y. Lin, J.H. Tsai
Primary Institution: Kaohsiung Medical College
Hypothesis
Is there a relationship between hepatitis B and C infections and raised alpha-fetoprotein levels in patients with hepatocellular carcinoma?
Conclusion
HCV infection is a significant risk factor for elevated alpha-fetoprotein levels in Chinese patients with hepatocellular carcinoma.
Supporting Evidence
- Patients with anti-HCV had a higher frequency of raised AFP (91.5%) compared to those without (65.2%).
- Serum AFP levels in patients with HCC were significantly higher than in healthy controls.
- Both HBV and HCV infections were identified as independent risk factors for HCC.
Takeaway
This study found that people with liver cancer and hepatitis C are more likely to have high levels of a specific protein called alpha-fetoprotein.
Methodology
The study involved 177 newly diagnosed HCC patients and 177 matched healthy controls, with serological tests for HBsAg and AFP.
Limitations
The study may not account for patients who are negative for HBsAg or anti-HCV but could still have HBV DNA or HCV RNA.
Participant Demographics
The study included 151 men and 26 women, aged 32 to 81 years, with a mean age of 59.
Statistical Information
P-Value
0.0001
Confidence Interval
95% CI (7.2-48.2)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website